Axxcess Wealth Management LLC Reduces Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Axxcess Wealth Management LLC lessened its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 1.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,043 shares of the company’s stock after selling 196 shares during the period. Axxcess Wealth Management LLC owned 0.15% of VanEck Pharmaceutical ETF worth $919,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of PPH. Financial Partners Group Inc purchased a new stake in VanEck Pharmaceutical ETF during the 2nd quarter worth about $8,701,000. J.Safra Asset Management Corp purchased a new stake in shares of VanEck Pharmaceutical ETF during the first quarter worth about $6,306,000. Bricktown Capital LLC purchased a new stake in shares of VanEck Pharmaceutical ETF during the second quarter worth about $5,904,000. Avestar Capital LLC acquired a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $4,284,000. Finally, Kingsview Wealth Management LLC lifted its stake in shares of VanEck Pharmaceutical ETF by 1,104.4% during the first quarter. Kingsview Wealth Management LLC now owns 30,194 shares of the company’s stock valued at $2,739,000 after buying an additional 27,687 shares during the period.

VanEck Pharmaceutical ETF Stock Performance

Shares of NASDAQ PPH opened at $97.18 on Friday. The firm has a market cap of $654.99 million, a P/E ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 1 year low of $74.05 and a 1 year high of $99.51. The firm’s 50 day moving average price is $95.42 and its 200 day moving average price is $91.66.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, July 5th. Stockholders of record on Monday, July 1st were issued a dividend of $0.3558 per share. The ex-dividend date of this dividend was Monday, July 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.